Zelavespib dihydrochlorideProduct ingredient for Zelavespib

Name
Zelavespib dihydrochloride
Drug Entry
Zelavespib

Zelavespib (PU-H71) has been used in trials studying the treatment of LYMPHOMA, Solid Tumors, Metastatic Solid Tumor, and Myeloproliferative Neoplasms (MPN).

Accession Number
DBSALT003292
Structure
Synonyms
8-(6-iodobenzo[1,3]dioxol-5-ylsufanyl)-9-(3-isopropylamino propyl)adenine dihydrochloride
UNII
ZEO4G69K8S
CAS Number
2249878-50-8
Not Available
Predicted Properties
Not Available